Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using placebos to manage postoperative pain

Official title: A Randomized Controlled Trial Evaluating the Efficacy of Conditioned Open Label Placebo (COLP) to Limit Opioid Reliance for Postoperative Pain Management

Run by Centre de Médecine Intégrative et Complémentaire (CEMIC) · NCT06107595 · Data updated 2026-11-12

This study is testing if using a special pill or scent along with regular pain medication can help patients after thoracic and spinal surgeries use less opioids and feel better.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment222 (estimated)
SponsorCentre de Médecine Intégrative et Complémentaire (CEMIC)
Academic / other
Locations1 site (Lausanne, Canton of Vaud)
StatusRecruiting
StartedJanuary 15, 2024
Main results expectedDecember 31, 2026
Study endsJune 30, 2027
Registry record updatedNovember 6, 2026
Trial IDNCT06107595 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults undergoing elective thoracic or spinal surgery who can provide informed consent and are interested in complementary pain management therapies.

Probably not a fit

Patients with cognitive impairments, severe psychiatric conditions, or those with opioid use disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of two types of Conditioned Open Label Placebos (COLP) - a pill and an odor - in reducing opioid consumption for patients recovering from thoracic and spinal surgeries. Eligible patients will be randomly assigned to receive either standard opioid treatment or one of the COLP interventions, where they will pair their opioid intake with a placebo. Participants will track their opioid use, pain levels, side effects, mobility, and sense of agency through an electronic diary over a period of 17 days post-surgery. The goal is to determine if these placebos can enhance pain management and reduce reliance on opioids.

Why it matters

Potential benefit: If successful, this approach could significantly reduce opioid intake and improve pain management for postoperative patients.

How similar studies have gone: While the use of placebos in pain management is a recognized area of interest, this specific approach using Conditioned Open Label Placebos is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Spinal or thoracic elective surgery for the indications mentioned above
* Able to give informed consent
* Interested in trying COLP as complementary pain management therapy
* Able to fill a e-diary at home

Exclusion Criteria:

* Cognitive impairment (MOCA score \<26)
* Inability to engage in the intervention of the study e.g. inability to communicate in French without a translator, severe hearing impairment without any hearing aid available at the time of intervention, anosmia or intolerance to eugenol.
* Acute psychiatric (e.g. psychotic or suicidal ideation) or somatic (e.g. unstable cardio-respiratory condition) co-morbidity preventing full engagement during intervention
* Opioid use disorder (toxicomania) or contraindication to pain management using opioids (allergy, refusal, ...)
* Intolerance to placebo ingredients

Where it's running

  • Centre de Médecine Intégrative et Complémentaire, Service d'anesthésiologie, CHUV,
    Lausanne, Canton of Vaud, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Chantal Berna Renella, Prof — Centre de Médecine Intégrative et Complémentaire, Lausanne University hospital
  • Study coordinator: Aurore Fernandez, PhD
  • Email: aurore.fernandez@chuv.ch
  • Phone: +41 79 556 66 91‬

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.